HutchMED (China) LIMITED Cash and Cash Equivalents, Fair Value Disclosure
HutchMED (China) LIMITED (HMDCF) had Cash and Cash Equivalents, Fair Value Disclosure of $377.54 million as of 2021-12-31, per its 20-F filed 2022-03-03.
Discontinued › Notes › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2022-03-03
- 2021-12-31: Cash and Cash Equivalents, Fair Value Disclosure $377.54M.
- 2020-12-31: Cash and Cash Equivalents, Fair Value Disclosure $235.63M.
- 2019-12-31: Cash and Cash Equivalents, Fair Value Disclosure $121.16M.
- 2018-12-31: Cash and Cash Equivalents, Fair Value Disclosure $86.04M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2021-12-31 | $377.54M 20-F · filed 2022-03-03 |
| 2020-12-31 | $235.63M 20-F · filed 2022-03-03 |
| 2019-12-31 | $121.16M 20-F · filed 2021-03-04 |
| 2018-12-31 | $86.04M 20-F · filed 2020-03-03 |
| 2017-12-31 | $85.27M 20-F · filed 2019-03-11 |
| 2016-12-31 | $79.43M 20-F · filed 2018-03-12 |
| 2015-12-31 | $31.94M 20-F · filed 2017-03-13 |